ArticleScientific reports2026
Crystallographic data for Pyrococcus furiosus dolichylphosphate mannose synthase suggest that the enzyme could flip its glycolipid product.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Real-time monitoring of glycocarrier formation unravels cryptic details in glycosyl transfer.RSC chemical biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dolichylphosphate mannose synthase (DPMS) performs an essential function by synthesizing the activated lipid-linked mannose intermediate used in protein glycosylation pathways. In eukaryotes and archaea, DPMS catalyzes the transfer of mannose from GDP-mannose to dolichylphosphate to generate dolichylphosphate mannose (Dol-P-Man). Type-III DPMS from Pyrococcus furiosus (PfDPMS) has a catalytic domain attached to a GtrA-like transmembrane (TM) domain with an unusual topology. Here, we present crystallographic data from a crystal complex determined from an enzymatic reaction mixture that provides detailed information about donor- and acceptor binding in the active site prior to mannosyl transfer. We also present a new, unexpected structural state for the TM domain in which a Dol-P-Man molecule is bound "upside-down" with its mannosylphosphate headgroup positioned in a polar pocket between the TM helices. By generating a panel of TM-domain mutants, we confirm that the TM domain does not participate directly in the catalysis of mannosyl transfer and discuss the possibility of this domain providing moonlighting function to PfDPMS by translocating the Dol-P-Man product to the cell exterior.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.